Skip to main content
logo
Suzhou Ribo Life Science Co., Ltd. (HKG:6938)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
49.90
-3.65 (-6.82%)
Jul 28, 2026, 4:08 PM HKT

Suzhou Ribo Life Science Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2019FY 2018
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '19 Dec '18
Revenue
148.51148.51142.630.04--
Revenue Growth
-17.56%4.13%324052.27%---
Gross Profit
121.73121.73115.65-24.98-1.96-2.44
Operating Income
-279.32-279.32-258.34-422.49-140.39-111.57
Net Income
-278.06-278.06-270.15-428.35-134.35-98.66
Earnings Per Share
-2.11-2.11-2.10-3.34-4.51-3.65
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Overseas
105.41105.41101.05-
Mainland China
43.143.141.580.04
Total
148.51148.51142.630.04

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2019FY 2018
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '19 Dec '18
Cash & Investments
408.34408.34185.16215.27238.12105.11
Total Debt
550.07550.07428.88414.7476.08-
Net Cash (Debt)
-141.73-141.73-243.72-199.47162.04105.11
Net Cash Growth
----54.16%-51.45%
Net Cash Per Share
-1.07-1.07-1.89-1.555.443.89

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2019FY 2018
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '19 Dec '18
Operating Cash Flow
-280.69-280.69-60.72-287.54-135.14-97.96
Capital Expenditures
-9.89-9.89-23.32-40-9.49-13.43
Free Cash Flow
-290.58-290.58-84.04-327.53-144.63-111.39
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2019FY 2018
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '19 Dec '18
Gross Margin
81.96%81.96%81.09%---
Operating Margin
-188.08%-188.08%-181.13%-960211.36%--
Pretax Margin
-191.61%-191.61%-180.22%-993518.18%--
Profit Margin
-187.23%-187.23%-189.41%-973520.46%--
FCF Margin
-195.66%-195.66%-58.92%-744395.46%--